Nov 14, 2023
Starpharma to present at Bell Potter Healthcare Conference (ASX Announcement)
Melbourne, Australia; 14 November 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) has been invited to present today at the Bell Potter Healthcare Conference, a virtual investor conference that showcases Australia's leading healthcare companies to institutional investors and Bell Potter’s retail network.
Starpharma will present an overview of the business, with a focus on recent milestones, including the positive clinical data reported for DEP® cabazitaxel1 and DEP® irinotecan2 in multiple cancers, as well as the positive preclinical data from the DEP® radiotheranostics programs.
The Bell Potter Healthcare Conference presentation is appended.
View/download the ASX Announcement, here.
1 ASX Announcement dated 18 October 2023: Positive DEP® Cabazitaxel Results in Multiple Cancers.
2 ASX Announcement dated 13 September 2023: Positive DEP® irinotecan clinical results to be presented at international oncology conference.